Sharma P, Eesa M, Scott JN (September 2009). "Toxic and acquired metabolic encephalopathies: MRI appearance". AJR Am J Roentgenol. 193 (3): 879–86. doi:10.2214/AJR.08.2257. PMID19696305.
Cerase A, Leonini S, Bellini M, Chianese G, Venturi C (July 2011). "Methadone-Induced Toxic Leukoencephalopathy: Diagnosis and Follow-up by Magnetic Resonance Imaging Including Diffusion-Weighted Imaging and Apparent Diffusion Coefficient Maps". Journal of Neuroimaging. 21 (3): 283–286. doi:10.1111/j.1552-6569.2010.00530.x. PMID20977538. S2CID1012350.
McKinney, Alexander; Stephen A. Kieffer; Rogerich T. Paylor; Karen S. SantaCruz; Ayse Kendi; Leandro Lucato (July 2009). "Acute Toxic Leukoencephalopathy: Potential for Reversibility Clinically and on MRI With Diffusion-Weighted and FLAIR Imaging". American Journal of Roentgenology. 193 (1): 192–206. doi:10.2214/Ajr.08.1176. PMID19542414.
González-Suárez I, Aguilar-Amat MJ, Trigueros M, Borobia AM, Cruz A, Arpa J (September 2013). "Leukoencephalopathy due to Oral Methotrexate". Cerebellum. 13 (1): 178–83. doi:10.1007/s12311-013-0528-1. PMID24068485. S2CID6854034.
Bathla, G; A.N. Hegde (May 2012). "MRI and CT appearances in metabolic encephalopathies due to systemic diseases in adults". Clinical Radiology. 22. 68 (6): 545–554. doi:10.1016/j.crad.2012.05.021. PMID23142023.
Hagel J, Andrews G, Vertinsky T, Heran MK, Keogh C (October 2005). ""Chasing the dragon" - Imaging of heroin inhalation leukoencephalopathy". Canadian Association of Radiologists Journal. 56 (4): 199–203. PMID16419370.
Sharma P, Eesa M, Scott JN (September 2009). "Toxic and acquired metabolic encephalopathies: MRI appearance". AJR Am J Roentgenol. 193 (3): 879–86. doi:10.2214/AJR.08.2257. PMID19696305.
Cerase A, Leonini S, Bellini M, Chianese G, Venturi C (July 2011). "Methadone-Induced Toxic Leukoencephalopathy: Diagnosis and Follow-up by Magnetic Resonance Imaging Including Diffusion-Weighted Imaging and Apparent Diffusion Coefficient Maps". Journal of Neuroimaging. 21 (3): 283–286. doi:10.1111/j.1552-6569.2010.00530.x. PMID20977538. S2CID1012350.
McKinney, Alexander; Stephen A. Kieffer; Rogerich T. Paylor; Karen S. SantaCruz; Ayse Kendi; Leandro Lucato (July 2009). "Acute Toxic Leukoencephalopathy: Potential for Reversibility Clinically and on MRI With Diffusion-Weighted and FLAIR Imaging". American Journal of Roentgenology. 193 (1): 192–206. doi:10.2214/Ajr.08.1176. PMID19542414.
González-Suárez I, Aguilar-Amat MJ, Trigueros M, Borobia AM, Cruz A, Arpa J (September 2013). "Leukoencephalopathy due to Oral Methotrexate". Cerebellum. 13 (1): 178–83. doi:10.1007/s12311-013-0528-1. PMID24068485. S2CID6854034.
Bathla, G; A.N. Hegde (May 2012). "MRI and CT appearances in metabolic encephalopathies due to systemic diseases in adults". Clinical Radiology. 22. 68 (6): 545–554. doi:10.1016/j.crad.2012.05.021. PMID23142023.
Iyer, Ramesh; Apeksha Chaturvedi; Sumit Pruthi; Paritosh C. Khanna; Gisele E. Ishak (November 2011). "Medication neurotoxicity in children". Pediatric Radiology. 41 (11): 1455–1464. doi:10.1007/s00247-011-2191-3. PMID21785849. S2CID20277034.
Cerase A, Leonini S, Bellini M, Chianese G, Venturi C (July 2011). "Methadone-Induced Toxic Leukoencephalopathy: Diagnosis and Follow-up by Magnetic Resonance Imaging Including Diffusion-Weighted Imaging and Apparent Diffusion Coefficient Maps". Journal of Neuroimaging. 21 (3): 283–286. doi:10.1111/j.1552-6569.2010.00530.x. PMID20977538. S2CID1012350.
González-Suárez I, Aguilar-Amat MJ, Trigueros M, Borobia AM, Cruz A, Arpa J (September 2013). "Leukoencephalopathy due to Oral Methotrexate". Cerebellum. 13 (1): 178–83. doi:10.1007/s12311-013-0528-1. PMID24068485. S2CID6854034.